newsfilter
← Latest News
PR Newswire·

Hoth Therapeutics Announces $2.0 Million Registered Direct Offering

Hoth Therapeutics, Inc. (Nasdaq: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for unmet medical...